MannKind Corp. (MNKD) reported that its public offering of stock and warrants worth at a 23% discount to Wednesday’s ending price.
The drug maker, which aims at cures for cancer and diabetes, stated that it will sell 40 million shares of stock, along with warrants to buy almost 30 million shares of its stock. Every share is being sold jointly with a warrant for $2 each, less than Wednesday’s ending price of $2.60. Each warrant permits the possessor to purchase 3/4 of a MannKind share.
Its competitors include Eli Lilly & Co. (NYSE:LLY) that slipped -0.34% to $53.49 with the total traded volume of 5.54 million shares and GlaxoSmithKline plc (ADR) (NYSE:GSK) that dropped -0.59% to $45.87 with the total traded volume of 2.11 million shares.
Other Healthcare stocks with bullish trend include Johnson & Johnson (NYSE:JNJ) up +1.76% to $72.25, Amarin Corporation plc (ADR) (NASDAQ:AMRN) up +5.85% to $11.95 and Pfizer Inc. (NYSE:PFE) up +0.68% to $26.01, whereas with bearish trend include Abbott Laboratories (NYSE:ABT) down -4.43% to $65.99, Boston Scientific Corporation (NYSE:BSX) down -2.31% to $5.49 and Align Technology, Inc. (NASDAQ:ALGN) down -25.16% to $26.51.
MannKind Corporation (NASDAQ:MNKD) stock in current session held volume of 25.92 million shares as compare to its average volume of 1.72 million shares. The stock after opening at $1.89 hit high price of $2.01 and then trading at $1.98 by scoring -23.85%.
The revenue measures MNKD twelve months income of $-149.55 million. Company’s annual sales growth for the past five years was -12.94%.
The stock showed weekly upbeat performance of +7.88% which was maintained for the month at -1.14%. Likewise the negative performance for the quarter was recorded as -2.99% and for the year was –16.67% while the YTD performance remained at +4.00%.
The MNKD past twelve months price to cash ratio remained 16.20. As far as the returns are concern, the MNKD was recorded decreased -76.35% return on investment while its return on asset stayed at -63.81%.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL
